<DOC>
	<DOCNO>NCT02606825</DOCNO>
	<brief_summary>This retrospective study analyze therapeutic result clinical evolution patient diagnose AML age ≥ 60años candidate chemotherapy intensive , treated accord different scheme available , include supportive care palliative .</brief_summary>
	<brief_title>VILMA : Therapeutic Results Acute Mieloblastic Leukemia Patients Older Than 60 Years</brief_title>
	<detailed_description>Approximately 6 month , collect review retrospective data . During period , order ensure excellent quality collect data , perform constant monitoring real-time data receive 2 phase : 1 . Monitoring `` situ '' focal point : information receive shall enter database , review case report data ( CRD ) screen inconsistency issue unresolved issue ( query ) sender data center . After enter information database carry resolve query arise consultation Data table order locate inconsistency unavailable field . 2 . Telephone Monitoring : data shall verify telephone consultation center verify update recruitment monitoring patient . To ensure completion , accuracy data quality monitor telephone least 30 % registered patient . - Final statistical analysis ( approximately 8 month baseline ) . - Publication result .</detailed_description>
	<criteria>Patients age ≥60 year , diagnose AML candidate intensive chemotherapy No exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>